Slight revenue growth despite the impact of the pandemic during the period
Sharp increase in order intake allowing anticipation of continued growth momentum in the second half of the year
EVRY, FRANCE, FRIDAY, JULY 16, 2021, 7:30 AM – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), a company specializing in the decryption of the human genome, which carries out interpretable genomic analyzes for academic and private laboratories, today announces its figure business, unaudited, for the first half of 2021.
The unaudited turnover for the first half of the year amounted to € 4,816K, up 2% compared to the first half of 2020 (€ 4,706K).
– .
